Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Phreesia, Inc. (PHR : NYSE)

• Company Description    Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. Number of Employees: 1,789

• Price / Volume Information    Yesterday's Closing Price: $10.22 Daily Weekly Monthly 20 Day Moving Average: 850,217 shares Shares Outstanding: 61.81 (millions) Market Capitalization: $631.72 (millions) Beta: 0.87 52 Week High: $32.76 52 Week Low: $7.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.94% 11.12% 12 Week 10.97% 7.93% Year To Date -39.60% -46.48%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1521 Concord Pike Suite 301 PMB 221 - Wilmington,DE 19803 USA ph: 888-654-7473 fax: 646-607-1776 investors@phreesia.com http://www.phreesia.com

• General Corporate Information    Officers Chaim Indig - Chief Executive Officer Michael Weintraub - Chairman Balaji Gandhi - Chief Financial Officer Yvonne Hui - SVP; Principal Accounting Officer Edward Cahill - Director Peer Information Phreesia, Inc. (HLIS) Phreesia, Inc. (AZTA) Phreesia, Inc. (APYI) Phreesia, Inc. (RNVA) Phreesia, Inc. (HMSY) Phreesia, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 71944F106 SIC: 7389 Fiscal Year Fiscal Year End: January Last Reported Quarter: 04/01/26 Next Expected EPS Date: 09/03/26 Share - Related Items Shares Outstanding: 61.81 Most Recent Split Date: (:1) Beta: 0.87 Market Capitalization: $631.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.10 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.39 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/03/26

• Fundamental Ratios P/E Current FY Estimate: 26.04 Trailing 12 Months: 36.50 PEG Ratio: - Price Ratios Price/Book: 1.76 Price/Cash Flow: 13.70 Price / Sales: 1.27 EPS Growth vs. Year Ago Period: 171.43% vs. Previous Quarter: -58.33% Sales Growth vs. Year Ago Period: 12.94% vs. Previous Quarter: 3.04% ROE 04/30/26 - 5.13 01/31/26 - 3.23 10/31/25 - -1.31 ROA 04/30/26 - 3.12 01/31/26 - 2.11 10/31/25 - -0.94 Current Ratio 04/30/26 - 1.76 01/31/26 - 1.53 10/31/25 - 2.44 Quick Ratio 04/30/26 - 1.76 01/31/26 - 1.53 10/31/25 - 2.44 Operating Margin 04/30/26 - 3.40 01/31/26 - 2.08 10/31/25 - -0.82 Net Margin 04/30/26 - 1.85 01/31/26 - 0.48 10/31/25 - -1.16 Pre-Tax Margin 04/30/26 - -0.21 01/31/26 - -1.86 10/31/25 - -0.86 Book Value 04/30/26 - 5.81 01/31/26 - 5.59 10/31/25 - 5.35 Inventory Turnover 04/30/26 - - 01/31/26 - - 10/31/25 - - Debt-to-Equity 04/30/26 - 0.41 01/31/26 - 0.41 10/31/25 - 0.01 Debt-to-Capital 04/30/26 - 28.92 01/31/26 - 28.96 10/31/25 - 1.04

Powered by Zacks Investment Research ©